Viatris Inc VTRS

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $16.24
Market Cap $18.69B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-3.0% YoY
$14.25B
3-Yr CAGR: -4.2%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↓-2.0% YoY
$1.94B
FCF Yield: 10.36%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (VTRS)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2018 $11,268.7M $4,001.6M $2,341.7M $2,089.6M
FY 2019 -100.0% $3,897.6M $-213.2M -110.2%
FY 2020 $11,819.9M $3,796.7M $1,231.8M $988.8M +563.8%
FY 2021 $17,813.6M +50.7% $5,575.5M $3,016.9M $2,559.7M +158.9%
FY 2022 $16,218.1M -9.0% $6,497.0M $2,952.6M $2,546.6M -0.5%
FY 2023 $15,388.4M -5.1% $6,438.6M $2,799.6M $2,422.6M -4.9%
FY 2024 $14,692.8M -4.5% $5,623.6M $2,302.9M $1,976.9M -18.4%
FY 2025 $14,250.4M -3.0% $5,013.5M $2,315.9M $1,937.1M -2.0%
$

Valuation

Market Price $16.24
Market Cap $18.69B
Enterprise Value $29.85B
P/E Ratio N/A
P/B Ratio 1.20
FCF Yield 10.36%
Dividend Yield N/A
Shares Outstanding 1,164,552,700
%

Profitability & Margins

Gross Margin 35.18%
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) N/A
Return on Assets (ROA) N/A
Asset Turnover 0.38x
Revenue 3-Yr CAGR -4.22%
🛡️

Financial Health & Liquidity

Current Ratio 0.44
Cash Ratio 0.40
Debt / Equity 0.794
Debt / Assets 0.336
Cash & Equivalents $1.32B
Total Debt $12.48B
Book Value / Share $13.50
💧

Cash Flow Efficiency

Operating Cash Flow $2.32B
Capital Expenditures (CapEx) $378.80M
Free Cash Flow $1.94B
OCF / Revenue 16.25%
FCF / Revenue 13.59%
FCF 3-Yr CAGR -8.72%
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $13.50
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $37.19B
Total Liabilities $22.48B
Stockholders' Equity $15.72B
Current Assets $1.44B
Current Liabilities $3.28B